Article Details
Retrieved on: 2021-07-22 11:37:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The agreement includes two open-label, dose escalation and expansion clinical studies to evaluate Adagene's anti-CTLA-4 monoclonal antibody (mAb) ...
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here